FT Diversified Target Income Portfolio, Series 6
Ticker Symbol: FPWJNX
Holdings (As of Day of Deposit) |
Ticker |
Company Name |
Initial
Weight |
Price* |
FTHI |
First Trust BuyWrite Income ETF |
25% |
$22.68 |
FTQI |
First Trust Nasdaq BuyWrite Income ETF |
25% |
20.08 |
RDVI |
FT Vest Rising Dividend Achievers Target Income ETF |
25% |
24.26 |
KNG |
FT Vest S&P 500® Dividend Aristocrats Target Income ETF® |
25% |
53.15 |
*As of the close of business on 8/28/24.
Market values are for reference only and are not indicative of your individual
cost basis.
Not FDIC Insured Not Bank Guaranteed May Lose Value |
Portfolio Summary |
Initial Date of Deposit |
8/29/2024 |
Initial Public Offering Price |
$10.00 per Unit |
Portfolio Ending Date |
12/1/2025 |
Historical 12-Month Distribution Rate of Trust Holdings* |
8.77% |
Historical 12-Month Distribution Per Unit* |
$0.8768 |
Cash
CUSIP |
30337J109 |
Reinvestment
CUSIP |
30337J117 |
Fee Accounts Cash CUSIP |
30337J125 |
Fee Accounts Reinvestment CUSIP |
30337J133 |
*There is no guarantee the issuers of the securities included in the trust will declare dividends or distributions
in the future. The historical 12-month distribution per unit and historical 12-month distribution rate of
the securities included in the trust are for illustrative purposes only and are not indicative of the trust’s
distribution or distribution rate. The historical 12-month distribution per unit is based on the weighted
average of the trailing 12-month distributions paid by the securities included in the portfolio. The historical
12-month distribution rate is calculated by dividing the historical 12-month distributions by the trust’s
offering price. The historical 12-month distribution and rate are reduced to account for the effects of fees
and expenses, which will be incurred when investing in a trust. Distributions may include realized short
term capital gains, realized long-term capital gains and/or return of capital. Certain of the issuers may have
reduced their dividends or distributions over the prior 12 months. The distribution per unit and rate paid by
the trust may be higher or lower than the amount shown above due to certain factors that may include, but
are not limited to, a change in the dividends or distributions paid by issuers, actual expenses incurred, or the
sale of securities in the portfolio.
Fee Table (based on a $10 public offering
price per unit) |
|
Standard |
Fee/Wrap |
Deferred Sales Charge |
1.50% |
— |
Maximum Sales Charge |
1.50% |
0.50% |
|
|
|
Estimated Organization Costs |
0.230% |
0.230% |
|
|
|
Operating Expenses |
0.216% |
0.216% |
Acquired Fund Fees and Expenses^ |
0.750% |
0.750% |
Estimated Annual Trust Operating Expenses |
0.966% |
0.966% |
^Although not actual trust operating expenses, the trust, and therefore unit holders, will indirectly bear
similar operating expenses of the funds in which the trust invests. These expenses are estimated and are
subject to change in the future.
The deferred sales charge will be deducted in three monthly installments commencing 12/20/24. When the
public offering price is less than or equal to $10.00 per unit, there will be no initial sales charge. If the price
exceeds $10.00 per unit, you will pay an initial sales charge. Estimated organization costs will be deducted
from the assets of the trust at the end of the initial offering period. Estimated organization costs and trust
operating expenses are assessed on a fixed dollar amount per unit basis which, as a percentage of average
net assets, will vary over time. Actual expenses may be more or less than the estimates. Please see “Fee Table”
in the trust prospectus for additional information.
You should consider the portfolio's investment objectives, risks, and
charges and expenses carefully before investing. Contact your financial professional
or call First Trust Portfolios, L.P. at 1.800.621.1675 to request a prospectus,
which contains this and other information about the portfolio. Read it carefully
before you invest.
Risk Considerations
An investment in this unmanaged unit investment trust should be made with an understanding of the risks associated with an investment in a portfolio of ETFs which invest in common stocks.
ETFs are subject to various risks, including management’s ability to meet the fund’s investment objective, and to manage the fund’s portfolio when the underlying securities are redeemed or sold, during periods of market
turmoil and as investors’ perceptions regarding ETFs or their underlying investments change. Unlike open-end funds, which trade at prices based on a current determination of the fund’s net asset value, ETFs frequently trade
at a discount from their net asset value in the secondary market.
Common stocks are subject to certain risks, such as an economic recession and the possible deterioration of either the financial condition of the issuers of the equity securities or the general condition of the stock market.
Options are subject to various risks including that their value may be adversely affected if the market for the option becomes less liquid or smaller. In addition, options will be affected by changes in the value and dividend rates
of the stock subject to the option, an increase in interest rates, a change in the actual and perceived volatility of the stock market and the common stock and the remaining time to expiration.
As the use of Internet technology has become more prevalent
in the course of business, the trust has become more
susceptible to potential operational risks through breaches in
cybersecurity.
Ongoing armed conflicts between Russia and Ukraine in Europe and among Israel, Hamas and other militant groups in the Middle East, have caused and could continue to cause significant market disruptions and volatility
within the markets in Russia, Europe, the Middle East and the United States. The hostilities and sanctions resulting from those hostilities could have a significant impact on certain investments as well as performance.
The ongoing effects of the COVID-19 global pandemic, or the potential impacts of any future public health crisis, may cause significant volatility and uncertainty in global financial markets. While vaccines have been developed, there is no guarantee that vaccines will be effective against future variants of the disease.
It is important to note that an investment can be made in the underlying funds directly rather than through the trust. These direct investments can be made without paying the trust’s sales charge, operating expenses and
organization costs.
The value of the securities held by the trust may be subject to
steep declines or increased volatility due to changes in
performance or perception of the issuers.
This UIT is a buy and hold strategy and investors should
consider their ability to hold the trust until maturity. There may
be tax consequences unless units are purchased in an IRA or
other qualified plan.
For a discussion of additional risks of investing in the trust see the “Risk Factors” section of the prospectus.
Nasdaq®, Nasdaq US Rising Dividend AchieversTM Index, and Nasdaq Composite Index are registered trademarks and service marks of Nasdaq, Inc. (together with its affiliates hereinafter referred to as the “Corporations”) and
are licensed for use by First Trust. The First Trust Nasdaq BuyWrite Income ETF and FT Vest Rising Dividend Achievers Target Income ETF have not been passed on by the Corporations as to its legality or suitability. The funds
are not issued, endorsed, sold or promoted by the Corporations. THE CORPORATIONS MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO THE FUND.
S&P® is a registered trademark of Standard & Poor’s Financial Services LLC (“S&P”), a division of S&P Global; Cboe® is a registered trademark of Cboe. The Index, S&P, and Cboe trademarks have been licensed for use by the
Sub-Advisor, and in turn, sub-licensed by the Advisor, including for use by the FT Vest S&P 500® Dividend Aristocrats Target Income ETF®. The fund is not sponsored, endorsed, sold, or promoted by Cboe and/or its affiliates
(the “Cboe Group”), or S&P and/or its affiliates (together, the “S&P Group”). Neither the Cboe Group nor the S&P Group make any representation regarding the advisability of investing in the fund and shall have no liability
whatsoever in connection with the fund.